Global Market Report from IDTechEx Research on Tissue Engineering 2018-2028: Technologies, Markets, Forecasts
IDTechEx Research forecasts the market for tissue engineered products to exceed $4.8 billion by the year 2028 in their report on the topic.
Tissue engineering, referring to the technologies that use physical, chemical, biological and engineering processes to control and direct the aggregate behaviour of cells, has become a field of increasing commercial interest. Though tissue engineering as a field has been around since the late 1970s, there have been few commercial successes. However, human understanding of biology, and our ability to manipulate it, has finally reached a point where complex living tissue equivalents are being developed. The IDTechEx Research report Tissue Engineering 2018-2028: Technologies, Markets, Forecasts investigates this next generation of tissue engineering products and their potential in the next 10 years.
This report covers living tissue equivalents which contain both living cells and a 3D structure.
Applications
The biggest applications for engineered tissues are in research and development, and in medicine. This report discusses the following key applications of tissue engineering:
Clinical Landscape
A chapter of Tissue Engineering 2018-2028: Technologies, Markets, Forecasts is dedicated to the use of tissue engineering products in medicine. The following classes of tissue engineered therapies are highlighted:
Additionally, a summary of ongoing clinical trials of tissue engineered products is provided, organized by trial phase, tissue type, and sponsor.
The rest of this chapter describes and discusses the dynamics of US and EU markets, with a look at relevant regulatory pathways, exemptions, and loopholes for tissue engineered products, as well as speculations on the future of regulating this novel class of therapy.
Market Forecasts
A market forecast for tissue engineered products is provided for the years 2018 - 2028, where the total value for tissue engineered products is predicted to surpass $4.8 billion. This market is broken down into key applications of therapies (clinical use) and tissue models (research use). Key players in both applications are presented, and the value chain and relevant business models are discussed.
Separately, a forecast for 3D bioprinters, an up-and-coming technology for tissue engineering, is also provided for the years 2018 - 2028.
Technology
A wide range of approaches are still being explored in tissue engineering, and this report covers both the most innovative and cutting-edge techniques as well as more established technologies. Technologies presented in Tissue Engineering 2018-2028: Technologies, Markets, Forecasts are:
For more information contact the IDTechEx Research team at research@IDTechEx.com or visit www.IDTechEx.com/tissue.
IDTechEx guides your strategic business decisions through its Research, Consultancy and Events services, helping you profit from emerging technologies. Find out more at www.IDTechEx.com.